Works about BEVACIZUMAB
Results: 5000
Olfactory Effects of Chemotherapy Combined with Bevacizumab on Advanced-Stage Colorectal Cancer Patients: Chemotherapy and Olfaction.
- Published in:
- Indian Journal of Otolaryngology & Head & Neck Surgery, 2025, v. 77, n. 2, p. 939, doi. 10.1007/s12070-024-05307-1
- By:
- Publication type:
- Article
Preserved bevacizumab (Avastin®) eye drops for application in multidose containers – an in-vitro characterisation.
- Published in:
- BMC Veterinary Research, 2025, v. 21, n. 1, p. 1, doi. 10.1186/s12917-025-04592-4
- By:
- Publication type:
- Article
Differences of frequency in administration of ranibizumab and bevacizumab in patients with neovascular AMD.
- Published in:
- Wiener Klinische Wochenschrift, 2014, v. 126, n. 11/12, p. 355, doi. 10.1007/s00508-014-0539-z
- By:
- Publication type:
- Article
Efficiently Reducing Medical Costs through Drug Vial Optimization and Multidose Vials for the Utilization of Cancer Drug Compounding Robots: Efficiently Reducing Medical Costs through Cancer Drug Compounding Robots: E. Usami et al.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 2, p. 75, doi. 10.1007/s40267-025-01140-w
- By:
- Publication type:
- Article
Targeted therapy for metastatic colorectal cancer: what do we currently have in clinical practice?
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 5, p. 222, doi. 10.1007/s40267-022-00915-9
- By:
- Publication type:
- Article
Novel concept of "sequential particle radiotherapy" with atezolizumab plus bevacizumab for hepatocellular carcinoma with portal vein tumor thrombus.
- Published in:
- Surgery Today, 2024, v. 54, n. 8, p. 972, doi. 10.1007/s00595-024-02805-1
- By:
- Publication type:
- Article
Phase II trial of induction chemotherapy with carboplatin and paclitaxel plus bevacizumab in patients with stage IIIA to IV nonsquamous non-small cell lung cancer.
- Published in:
- Surgery Today, 2019, v. 49, n. 8, p. 678, doi. 10.1007/s00595-019-01791-z
- By:
- Publication type:
- Article
High serum levels of interleukin-6 in patients with advanced or metastatic colorectal cancer: the effect on the outcome and the response to chemotherapy plus bevacizumab.
- Published in:
- Surgery Today, 2017, v. 47, n. 4, p. 483, doi. 10.1007/s00595-016-1404-7
- By:
- Publication type:
- Article
The effects of bevacizumab on intestinal anastomotic healing in rabbits.
- Published in:
- Surgery Today, 2016, v. 46, n. 12, p. 1456, doi. 10.1007/s00595-016-1342-4
- By:
- Publication type:
- Article
Effects of vascular formation during alveolar bone process morphogenesis in mice.
- Published in:
- Histochemistry & Cell Biology, 2017, v. 148, n. 4, p. 435, doi. 10.1007/s00418-017-1584-2
- By:
- Publication type:
- Article
Tumor vessel stabilization and remodeling by anti-angiogenic therapy with bevacizumab.
- Published in:
- Histochemistry & Cell Biology, 2012, v. 137, n. 3, p. 391, doi. 10.1007/s00418-011-0898-8
- By:
- Publication type:
- Article
Late-line treatment with bevacizumab alone or in combination with chemotherapy in recurrent high-grade gliomas.
- Published in:
- Acta Neurochirurgica, 2023, v. 165, n. 3, p. 693, doi. 10.1007/s00701-023-05524-7
- By:
- Publication type:
- Article
The role of bevacizumab for treatment-refractory intracranial meningiomas: a single institution's experience and a systematic review of the literature.
- Published in:
- Acta Neurochirurgica, 2022, v. 164, n. 11, p. 3011, doi. 10.1007/s00701-022-05348-x
- By:
- Publication type:
- Article
Non-occlusive mesenteric ischemia during bevacizumab treatment for glioblastoma: a case report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Intravitreal Aflibercept Therapy in Intravitreal Bevacizumab/Ranibizumab Treatment-resistant Exudative Age-related Macular Degeneration.
- Published in:
- Bosphorus Medical Journal / Boğaziçi Tıp Dergisi, 2023, v. 10, n. 3, p. 179, doi. 10.14744/bmj.2023.18199
- By:
- Publication type:
- Article
The Use of Bevacizumab Alone and in Combination with Classical Chemotheropathics in Ishikawa Endometrial Cancer Cell Culture.
- Published in:
- Acibadem Saglik Bilimleri Dergisi, 2021, v. 12, n. 3, p. 651, doi. 10.31067/acusaglik.915637
- By:
- Publication type:
- Article
Clearance of circulating tumor DNA in a high-risk stage-IV rectal carcinoma patient with synchronous liver metastases after conversion surgery is correlated with pathologic complete response.
- Published in:
- Therapeutic Advances in Gastrointestinal Endoscopy, 2021, p. 1, doi. 10.1177/26317745211020279
- By:
- Publication type:
- Article
Antiangiogeneic Activity of Annona Reticulata Seeds Extract.
- Published in:
- Iraqi Journal of Cancer & Medical Genetics, 2022, v. 15, n. 1, p. 19
- By:
- Publication type:
- Article
Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00297-5
- By:
- Publication type:
- Article
Glioblastoma Break-in; Try Something New.
- Published in:
- International Journal of Cancer Management, 2021, v. 14, n. 1, p. 1, doi. 10.5812/ijcm.109054
- By:
- Publication type:
- Article
Immunogenicity of Rituximab, Trastuzumab, and Bevacizumab Monoclonal Antibodies in Patients with Malignant Diseases.
- Published in:
- International Journal of Cancer Management, 2018, v. 11, n. 11, p. 1, doi. 10.5812/ijcm.64983
- By:
- Publication type:
- Article
A retrospective study assessing the factors associated with visual outcome in retinal vein occlusion patients after anti-VEGF therapy.
- Published in:
- PeerJ, 2021, p. 1, doi. 10.7717/peerj.12599
- By:
- Publication type:
- Article
Colorectal Cancer: To Stack or Sequence Therapy?
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 5, p. 6, doi. 10.1093/jnci/djv138
- By:
- Publication type:
- Article
Tumor Location in Colorectal Cancer May Influence Survival.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 3, p. 1, doi. 10.1093/jnci/djv058
- Publication type:
- Article
The Bipartisan Colon.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 3, p. 1, doi. 10.1093/jnci/dju427
- By:
- Publication type:
- Article
Promising Early Results for Immunotherapy-Antiangiogenesis Combination.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 11, p. 2, doi. 10.1093/jnci/dju392
- By:
- Publication type:
- Article
Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer: Findings from NSABP C-08.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 13, p. 989, doi. 10.1093/jnci/djt140
- By:
- Publication type:
- Article
Avastin Saga Reveals Debate Over Clinical Trial Endpoints.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 11, p. 800, doi. 10.1093/jnci/djs265
- By:
- Publication type:
- Article
Physician Data Query (PDQ®) Update.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 5, p. 355, doi. 10.1093/jnci/djs159
- Publication type:
- Article
Targeted Therapies for Renal Cell Carcinoma: Review of Adverse Event Management Strategies.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 2, p. 93, doi. 10.1093/jnci/djr511
- By:
- Publication type:
- Article
Ovarian Cancer Treatments on the Horizon.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 17, p. 1284, doi. 10.1093/jnci/djr343
- By:
- Publication type:
- Article
StatBite Avastin Quarterly Sales, 2009-2011.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 15, p. 1149, doi. 10.1093/jnci/djr294
- Publication type:
- Article
Avastin Hearing Leads to More Uncertainty Over Drug’s Future.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 15, p. 1148, doi. 10.1093/jnci/djr293
- By:
- Publication type:
- Article
Avastin's Uncertain Future in Breast Cancer Treatment.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 6, p. 458, doi. 10.1093/jnci/djr088
- By:
- Publication type:
- Article
FDA Increases Focus on Postmarketing Studies.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 17, p. 1302, doi. 10.1093/jnci/djq350
- By:
- Publication type:
- Article
Response: Re: How Much Is Life Worth: Cetuximab, Non–Small Cell Lung Cancer, and the $440 Billion Question.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 15, p. 1207, doi. 10.1093/jnci/djq247
- By:
- Publication type:
- Article
Antiangiogenesis Research Is Booming, As Questions and Studies Proliferate.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 11, p. 780, doi. 10.1093/jnci/djp150
- By:
- Publication type:
- Article
Review of real-world evidence of dual inhibition of VEGF-A and ANG-2 with faricimab in NAMD and DME.
- Published in:
- International Journal of Retina & Vitreous, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40942-024-00525-9
- By:
- Publication type:
- Article
Comparison of antiangiogenic agents (ranibizumab, aflibercept, bevacizumab and ziv-aflibercept) in the therapeutic response to the exudative form of age-related macular degeneration according to the treat-and-extend protocol- true head-to-head study.
- Published in:
- International Journal of Retina & Vitreous, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40942-024-00537-5
- By:
- Publication type:
- Article
Reuse of shipping materials in the intravitreal bevacizumab supply chain: feasibility, cost, and environmental impact.
- Published in:
- International Journal of Retina & Vitreous, 2023, v. 9, n. 1, p. 1, doi. 10.1186/s40942-023-00474-9
- By:
- Publication type:
- Article
Pre-operative intravitreal bevacizumab for tractional retinal detachment secondary to proliferative diabetic retinopathy: the Alvaro Rodriguez lecture 2023.
- Published in:
- International Journal of Retina & Vitreous, 2023, v. 9, n. 1, p. 1, doi. 10.1186/s40942-023-00467-8
- By:
- Publication type:
- Article
Intravitreal bevacizumab plus propranolol for neovascular age-related macular degeneration (the BEVALOL study): a phase I clinical trial.
- Published in:
- International Journal of Retina & Vitreous, 2023, v. 9, n. 1, p. 1, doi. 10.1186/s40942-023-00460-1
- By:
- Publication type:
- Article
Combined intravitreal dexamethasone and bevacizumab injection for the treatment of persistent diabetic macular edema (DexaBe study): a phase I clinical study.
- Published in:
- International Journal of Retina & Vitreous, 2023, v. 9, n. 1, p. 1, doi. 10.1186/s40942-023-00449-w
- By:
- Publication type:
- Article
Polypoidal choroidal vasculopathy—characteristics and response to treatment with bevacizumab in caucasian patients.
- Published in:
- International Journal of Retina & Vitreous, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40942-022-00432-x
- By:
- Publication type:
- Article
Short-term outcomes in patients with center-involving diabetic macular edema after a single dose of intravitreal bevacizumab.
- Published in:
- International Journal of Retina & Vitreous, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40942-022-00430-z
- By:
- Publication type:
- Article
Evaluation of the additive effect of interferon α 2b with monthly intravitreal injection of bevacizumab in refractory diabetic macular edema.
- Published in:
- International Journal of Retina & Vitreous, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40942-022-00424-x
- By:
- Publication type:
- Article
Combined intravitreal injection of bevacizumab and a ROCK inhibitor (fasudil) for refractory macular edema secondary to retinal vein occlusion: a pilot study.
- Published in:
- International Journal of Retina & Vitreous, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40942-022-00389-x
- By:
- Publication type:
- Article
Future of anti-VEGF: biosimilars and biobetters.
- Published in:
- International Journal of Retina & Vitreous, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40942-021-00343-3
- By:
- Publication type:
- Article
Growth and neurodevelopmental status in patients with retinopathy of prematurity treated with intravitreal bevacizumab: a case–control study.
- Published in:
- International Journal of Retina & Vitreous, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s40942-021-00340-6
- By:
- Publication type:
- Article